Key facts
- Notable investors include QHP Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vector Clinical Trials
- ·The full record, as it builds
Funding rounds
No funding rounds for Vector Clinical Trials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vector Clinical Trials
Provider of clinical research services intended to support drug development and regulatory approval processes. The company conducts short-term trials for investigational medications targeting specific medical concerns and facilitates public participation through free consultations, thereby contributing to safer treatments for future use.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Website
- vectorclinicaltrials.com/
- Ownership
- Privately Held (backing)
Vector Clinical Trials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vector Clinical Trials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vector Clinical Trials in its N-PORT filings yet. We sweep new filings monthly.